Betsi Cadwaladr University Local Health Board ... - Health in Wales
Betsi Cadwaladr University Local Health Board ... - Health in Wales
Betsi Cadwaladr University Local Health Board ... - Health in Wales
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
arrangements for specialist commission<strong>in</strong>g under the Welsh <strong>Health</strong> Specialised<br />
Services Committee (WHSSC). However, as these arrangements have not yet been<br />
f<strong>in</strong>alised, it is assumed that any fund<strong>in</strong>g requests for services currently commissioned<br />
by HCW will cont<strong>in</strong>ue to be processed by HCW. This will be until such time that the<br />
new arrangements for tertiary services are <strong>in</strong> place at which po<strong>in</strong>t this procedure will<br />
be amended accord<strong>in</strong>gly.<br />
Extra Contractual Referrals (ECR)<br />
1.8 Treatments or Services provided by an <strong>in</strong>dependent or private health service<br />
provider are termed extra contractual referrals or ECR.<br />
Non Contracted Activity (NCA)<br />
1.9 Treatments or Services provided by other NHS organisations with which the<br />
<strong>Local</strong> <strong>Health</strong> <strong>Board</strong> does not hold an exist<strong>in</strong>g Long Term Agreement (LTA) or<br />
contracts, are termed non contracted activity or NCA.<br />
1.10 Elective and non emergency NCAs need prior authorisation from the LHB and<br />
should be considered on an <strong>in</strong>dividual case by case basis. However, emergency or<br />
immediately necessary treatments do not need prior authorisation from the LHB and<br />
although these tend to be low volume, they are funded from current LHB revenue and<br />
so therefore present an <strong>in</strong>-year f<strong>in</strong>ancial risk for the LHB.<br />
Named Patient Contacts (NPC)<br />
1.11 Treatments or Services by an NHS organisation which is prepared to provide a<br />
specific treatment/service outside the normal LHB contracts are termed Named<br />
Patient Contacts or NPC. This mechanism may be used where a provider is<br />
unwill<strong>in</strong>g, or it is <strong>in</strong>appropriate, to use the NCA process because of high and/or<br />
variable costs <strong>in</strong>volved. This will often apply to specialised services or new services<br />
be<strong>in</strong>g offered by the NHS organisation.<br />
Named Patient Variations (NPV)<br />
1.12 Treatments or Services by an NHS organisation which are variations to an<br />
exist<strong>in</strong>g LTA or contract and which may <strong>in</strong>volve additional fund<strong>in</strong>g to support<br />
enhanced service levels/treatments to <strong>in</strong>dividual patients are termed Named Patient<br />
Variations (NPV)<br />
Low Effectiveness Procedures (LEPs)<br />
1.13 Appendix 1 lists cl<strong>in</strong>ical <strong>in</strong>terventions of limited or unknown cl<strong>in</strong>ical value.<br />
These <strong>in</strong>terventions are rout<strong>in</strong>ely considered to be of low priority and are not normally<br />
used by the NHS. These <strong>in</strong>terventions have been split between those that should not<br />
be used <strong>in</strong> any circumstance and those that should not be used except under strict<br />
criteria. The latter are subdivided between lower volume (20/year) treatments, accord<strong>in</strong>g to an analysis across North <strong>Wales</strong><br />
undertaken <strong>in</strong> 2009 by Public <strong>Health</strong> <strong>Wales</strong> 1 . Where applicable the specific<br />
circumstances/strict criteria under which use can be considered by the UHB, are set<br />
out together with reference l<strong>in</strong>ks to the available evidence. Procedures will be subject<br />
to the process outl<strong>in</strong>ed <strong>in</strong> Section 3 of this policy. In addition, it will be necessary for<br />
procedures of higher volume to be subject to <strong>in</strong>vestigation and cont<strong>in</strong>uous review to<br />
ensure that the UHB position and <strong>in</strong>terpretation of evidence cont<strong>in</strong>ues to be<br />
4